Citadel Advisors »

Dexcom Inc Note 0.375 5/1 shares owned by Citadel Advisors

Quarter-by-quarter ownership of Dexcom Inc Note 0.375 5/1 shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Dexcom Inc Note 0.375 5/1

Tip: Access up to 7 years of quarterly data

All positions including Dexcom Inc Note 0.375 5/1 held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dexcom Inc Note 0.375 5/1 by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $19M 21M 0.91
2024-09-30 $24M 27M 0.89

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Dexcom Inc Note 0.375 5/1

Steelhead Partners
BlackRock
CNH Partners
Camden Asset Management
Franklin Resources
Magnetar Financial
Sona Asset Management
Lazard Asset Management
OZ Management
DeepCurrents Investment Group
Advent Capital Management
MacKay Shields
Jpmorgan Chase & Co
Calamos Advisors
Bnp Paribas Arbitrage, Snc

View all funds holding Dexcom Inc Note 0.375 5/1